DexCom's third-quarter revenue rose by 11%, boosted by US growth of 14% while international sales rose 5%. Gross margin rose to 64%, roughly 380 basis points higher than in the prior-year period.
DexCom's G7 product is significantly less expensive and offers a thinner profile and faster warm-up time than the G6.
Considering DexCom's sensors are already the most accurate, there's less opportunity for significant improvements on that dimension, compared with key competitors.
|
Metric
|
DXCM
|
ABT
|
MDT
|
|---|---|---|---|
Price/Earnings (Normalized) | 32.25 | 24.59 | 17.06 |
Price/Book Value | 12.11 | 3.60 | 2.46 |
Price/Sales | 6.31 | 3.84 | 3.31 |
Price/Cash Flow | 14.68 | 16.96 | 13.85 |
|
Metric
|
DXCM
|
ABT
|
MDT
|
|---|---|---|---|
Quick Ratio | 1.34 | 0.97 | 1.29 |
Current Ratio | 1.74 | 1.38 | 2.07 |
Interest Coverage | 89.67 | 10.40 | 10.12 |
|
Metric
|
DXCM
|
ABT
|
MDT
|
|---|---|---|---|
Return on Assets (Normalized) | 17.74% | — | 8.31% |
Return on Equity (Normalized) | 43.30% | — | 15.59% |
Return on Invested Capital (Normalized) | 25.98% | — | 10.57% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|<S^?!< | LOCK|fzt? | $184B | |||
| Medtronic PLC
MDT
| LOCK|ym?M$b | LOCK|vrZx& | $123B | |||
| Stryker Corp
SYK
| LOCK|Y?@?<<^W | LOCK|>R | $111B | |||
| Boston Scientific Corp
BSX
| LOCK|N?@^rH& | LOCK|?nKM | $61B | |||
| Edwards Lifesciences Corp
EW
| LOCK|DGdZC^fN | LOCK|p#?>v | $53B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|F?<&TY | LOCK|>r | $35B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|xxv | LOCK|L<j | $26B | |||
| Steris PLC
STE
| LOCK|rnkNYc | LOCK|jBST | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|B!y@hNs | LOCK|C!y | $18B |
United States